Fathia DJELTI-DELBARBA

Dr. Fathia DJELTI-DELBARBA

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AHAseel El Hajj
Aseel El Hajj
AHAmeziane HERZINE
Ameziane HERZINE
GCGaetano CALCAGNO
Gaetano CALCAGNO
FDFrédéric Desor
Frédéric Desor
FDFathia DJELTI-DELBARBA
Fathia DJELTI-DELBARBA
TCThomas Claudepierre
Thomas Claudepierre
Perturbations of cholesterol metabolism have been linked to neurodegenerative diseases. Glia–neuron crosstalk is essential to achieve a tight regulation of brain cholesterol trafficking. Adequate cholesterol supply from glia via apolipoprotein E-containing lipoproteins ensures neuronal development and function. The lipolysis-stimulated lipoprotein receptor (LSR), plays an important role in brain cholesterol homeostasis. Aged heterozygote Lsr+/− mice show altered brain cholesterol distribution and increased susceptibility to amyloid stress. Since LSR expression is higher in astroglia as compared to neurons, we sought to determine if astroglial LSR deficiency could lead to cognitive defects similar to those of Alzheimer’s disease (AD). Cre recombinase was activated in adult Glast-CreERT/lsrfl/fl mice by tamoxifen to induce astroglial Lsr deletion. Behavioral phenotyping of young and old astroglial Lsr KO animals revealed hyperactivity during the nocturnal period, deficits in olfactory function affecting social memory and causing possible apathy, as well as visual memory and short-term working memory problems, and deficits similar to those reported in neurodegenerative diseases, such as AD. Furthermore, GFAP staining revealed astroglial activation in the olfactory bulb. Therefore, astroglial LSR is important for working, spatial, and social memory related to sensory input, and represents a novel pathway for the study of brain aging and neurodegeneration.

28 February 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
FPFabien Pifferi
Fabien Pifferi
JTJérémy Terrien
Jérémy Terrien
JMJulia Marchal
Julia Marchal
ADAlexandre Dal-Pan
Alexandre Dal-Pan
FDFathia DJELTI-DELBARBA
Fathia DJELTI-DELBARBA
FAFabienne Aujard
Fabienne Aujard
Resveratrol (RSV), a polyphenol with anti-aging properties affecting metabolism and energy balance, is considered as a mimetic candidate to calorie restriction (CR). However its potential effects on delaying the onset of age-related diseases and increasing longevity have not yet been demonstrated in non-obese models close to humans such as non-human primates. The longitudinal monitoring of cognitive and motor performances, occurrence of age-related pathologies, age-related brain atrophy and mortality was performed from adulthood to death in a cohort of male grey mouse lemurs (Microcebus murinus, N = 33), all receiving 105 kJ/day of food but with a subset of 18 animals receiving RSV (200 mg.kg-1 body weight.day-1). RSV supplementation improved cognitive and motor performance at middle age as compared to control (CTL) animals. Median-lifespan was greater in RSV-fed animals (7.9 years compared to 6.4 years for CTL) but long-term RSV supplementation did not significantly affect all-cause nor age-related mortality. Also, brain grey matter atrophy accelerated in the RSV group at old age as compared to the CTL group. Altogether, these results suggest that long-term RSV supplementation procures health benefits at middle-age in male mouse lemurs but has limited long-term effects on health and longevity and might even impair brain integrity at older ages.

Verified
Journal Article
Open access
PDF file
MVMaxime Vigier
Maxime Vigier
MUMagalie Uriot
Magalie Uriot
FDFathia DJELTI-DELBARBA
Fathia DJELTI-DELBARBA
TCThomas Claudepierre
Thomas Claudepierre
AHAseel El Hajj
Aseel El Hajj
CMCatherine Malaplate
Catherine Malaplate
Docosahexaenoic acid (DHA, C22:6 ω3) may be involved in various neuroprotective mechanisms that could prevent Alzheimer’s disease (AD). Its influence has still been little explored regarding the dysfunction of the endolysosomal pathway, known as an early key event in the physiopathological continuum triggering AD. This dysfunction could result from the accumulation of degradation products of the precursor protein of AD, in particular the C99 fragment, capable of interacting with endosomal proteins and thus contributing to altering this pathway from the early stages of AD. This study aims to evaluate whether neuroprotection mediated by DHA can also preserve the endolysosomal function. AD-typical endolysosomal abnormalities were recorded in differentiated human SH-SY5Y neuroblastoma cells expressing the Swedish form of human amyloid precursor protein. This altered phenotype included endosome enlargement, the reduced secretion of exosomes, and a higher level of apoptosis, which confirmed the relevance of the cellular model chosen for studying the associated deleterious mechanisms. Second, neuroprotection mediated by DHA was associated with a reduced interaction of C99 with the Rab5 GTPase, lower endosome size, restored exosome production, and reduced neuronal apoptosis. Our data reveal that DHA may influence protein localization and interactions in the neuronal membrane environment, thereby correcting the dysfunction of endocytosis and vesicular trafficking associated with AD.

28 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
FDFrédéric Desor
Frédéric Desor
AHAseel El Hajj
Aseel El Hajj
AHAmeziane HERZINE
Ameziane HERZINE
FDFathia DJELTI-DELBARBA
Fathia DJELTI-DELBARBA
VBVincent Bombail
Vincent Bombail
TCThomas Claudepierre
Thomas Claudepierre
CRE recombinase is a protein that recognizes and mediates site-specific recombination between loxP site sequences. The Cre/loxP recombination system has become a useful tool for genetic manipulation. Spatial regulation of recombination can be achieved by using cell type-specific promoters that drive expression of CRE in the tissue of interest. The temporal regulation can be obtained with CreER recombinase, which consists of Cre fused to mutated hormone-binding domain of the estrogen receptor (ER). In the more improved versions of the construct, the CRE - mediated gene regulation can be controlled both spatially and temporally, by combining tissue-specific expression of a CreER recombinase with its tamoxifen-dependent activity. We recently generated and characterized an astrocyte specific mutant of the lipolysis-stimulated lipoprotein receptor lsr gene by crossing Glast ERT2 mice with floxed lsr mice (El Hajj et al., 2022). During the behavioral analysis of generated mice, we identified specific hyperactive traits in the Glast ERT2 mice (CRE mice) that prevented them from being used as a control group. Here we further assessed the hyperactive trait of those CRE mice using a battery of behavioral tests. We showed that CRE mice exhibited hyperactive behavior combined with attention-deficit, sleep disturbance and impulsivity that affect their learning and memorization performances. These mice may therefore serve as a model to study attention deficit / hyperactivity disorder. Our work also pointed out the need for proper behavioral analysis of control groups in transgenic animal generation to avoid misinterpretation and misattribution of behavioral traits.

31 March 2026
Verified
Thesis
Closed access
FDFathia DJELTI-DELBARBA
Fathia DJELTI-DELBARBA
Le vieillissement normal s’accompagne d’une diminution du contenu du cholestérol cérébral. Au contraire, une accumulation de cholestérol est associée aux processus toxiques dans plusieurs pathologies dégénératives (maladie d’Huntington, maladie de Parkinson, épilepsie, maladie de Niemann Pick de type C, maladie d’Alzheimer). De plus, les parallèles étroits existent entre la physiopathologie moléculaire de la maladie d’Alzheimer et celle de la maladie de Niemann Pick de type C, maladie de l’homéostasie du cholestérol. Ainsi on retrouve dans ces deux pathologies une hyperphosphorylation de la protéine Tau, associée à une augmentation des endosomes élargis et à la production de peptides A. L’ensemble de ces éléments évoque le rôle potentiel de la surcharge en cholestérol cérébral comme facteur favorisant le développement de la maladie d’Alzheimer. L’objectif de mon travail de doctorat a été de déterminer si une surcharge en cholestérol in vivo dans les neurones de l’hippocampe, région précocement touchée par la maladie d’Alzheimer, pouvait être à l’origine de processus neurotoxiques et de modifications biochimiques et neuropathologiques proches de ceux qui sont observés dans cette pathologie. La quasi-totalité du cholestérol cérébral est synthétisée in situ, la barrière hémato-encéphalique ne permettant qu’un apport minime du cholestérol périphérique. L’excès de cholestérol est exporté de la circulation sanguine sous la forme du 24-hydroxycholestérol, un métabolite produit exclusivement dans les neurones par la cholestérol-24-hydroxylase codée par le gène Cyp46a1.La surcharge en cholestérol a été induite in vivo par inhibition de la cholestérol-24-hydroxylase, dans l’hippocampe par une stratégie d’ARN interférence délivré par une injection stéréotaxique d’un vecteur AAV5. Nous avons étudié, d’une part la capacité d’une accumulation de cholestérol à induire chez la souris normale, un phénotype clinique et neuropathologique proche de la maladie d’Alzheimer et d’autre part si cette même accumulation de cholestérol neuronal pouvait aggraver ou compléter le phénotype Alzheimer d’un modèle murin de la maladie, la souris APP23. L’injection du vecteur AAV5-shCYP46A1 dans la stratum lacunosum moleculare de l’hippocampe conduit à une inhibition significative de l'expression du gène Cyp46a1, associée à une diminution de la concentration du 24-hydroxycholestérol et une augmentation du contenu en cholestérol dans les neurones de l’hippocampe, 3 semaines après l’injection. En réponse à cet excès de cholestérol, des mécanismes régulateurs permettent de diminuer, d’une part l’import et d’augmenter l’export du cholestérol de la cellule et d’autre part d’augmenter le contenu en phosphatidylcholine afin de rétablir un ratio phospholipide/cholestérol physiologique. Cependant, l'accumulation majeure de cholestérol intracellulaire conduit, 3 semaines après l’injection, à une activation de la réponse UPR (Unfolded Protein Response ou stress du réticulum endoplasmique) caractérisée par l'expression des gènes codant les facteurs XBP1s, ATF6, GRP78 associée à celles des protéines PERK phosphorylée, CHOP et caspase 12, entraînant l'activation des caspases 9 et 3. Elle est associée à la phosphorylation des protéines GSK3 (Tyr216) et Tau (Thr231). En parallèle, l’augmentation du cholestérol induit, 3 semaines après l’injection, une augmentation de l’expression de la protéine Rab5 (marqueur des endosomes précoces) et une relocalisation de la protéine APP dans les fractions de radeaux lipidiques associées à l'activation de la voie amyloïdogénique (production des fragments-CTF et des peptides A42). L’étude lipidomique met en évidence, 4 semaines après l’injection, une augmentation du contenu en céramide à longues chaînes et à une augmentation des gangliosides. Tous ces éléments aboutissent à un processus de perte neuronale associée à un recrutement des astrocytes dès la quatrième semaine après l’injection....